A new drug for managing both nasal and ocular symptoms of allergic rhinitis: fluticasone furoate nasal spray.
Enoz
Murat
M
Inancli
Hasan Mete
HM
Lapeña
Jose Florencio
JF
Hafiz
Gunter
G
D000280:Administration, Inhalation; D000730:Androstadienes / Q000008:administration & dosage*; D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005123:Eye / Q000187:drug effects; D005260:Female; D000068298:Fluticasone; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009296:Nasal Cavity / Q000187:drug effects; D059085:Nasal Sprays; D012189:Retrospective Studies; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000730:Androstadienes; D018926:Anti-Allergic Agents; D059085:Nasal Sprays; D000068298:Fluticasone